hydroxyindoleacetic acid has been researched along with Marfan Syndrome, Type I in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stoerner, JW | 1 |
| Butler, IJ | 1 |
| Morriss, FH | 1 |
| Howell, RR | 1 |
| Seifert, WE | 1 |
| Caprioli, RM | 1 |
| Adcock, EW | 1 |
| Denson, SE | 1 |
1 other study available for hydroxyindoleacetic acid and Marfan Syndrome, Type I
| Article | Year |
|---|---|
CSF neurotransmitter studies. An infant with ascorbic acid-responsive tyrosinemia.
Topics: Ascorbic Acid; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant, Newborn | 1980 |